Cited by

• COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.

  Rahmani M, Moghadasi AN, Shahi S, Eskandarieh S, Azizi H, Hasanzadeh A, Ahmadzade A, Dehnavi AZ, Farahani RH, Aminianfar M, Naeini AR. Rahmani M, et al. Med Clin (Barc). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcli.2022.06.020. Epub 2022 Aug 10. Med Clin (Barc). 2023. PMID: 36089420 Free PMC article.
• How Early Is Early Multiple Sclerosis?

  Stavropoulou De Lorenzo S, Bakirtzis C, Konstantinidou N, Kesidou E, Parissis D, Evangelopoulos ME, Elsayed D, Hamdy E, Said S, Grigoriadis N. Stavropoulou De Lorenzo S, et al. J Clin Med. 2023 Dec 29;13(1):214. doi: 10.3390/jcm13010214. J Clin Med. 2023. PMID: 38202221 Free PMC article. Review.
• A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

  Collins RC, Espinoza LR, Plank CR, Ebers GC, Rosenberg RA, Zabriskie JB. Collins RC, et al. Clin Exp Immunol. 1978 Jul;33(1):1-11. Clin Exp Immunol. 1978. PMID: 361313 Free PMC article. Clinical Trial.
• Clinical studies of multiple sclerosis in Japan. Multiple sclerosis starting with retrobulbar neuritis.

  Shibasaki H, Kuroda Y, Iwashita H, Kuroiwa Y. Shibasaki H, et al. J Neurol. 1974;208(1):17-25. doi: 10.1007/BF00313330. J Neurol. 1974. PMID: 4140896 No abstract available.
• Selective loss of a subset of T helper cells in active multiple sclerosis.

  Rose LM, Ginsberg AH, Rothstein TL, Ledbetter JA, Clark EA. Rose LM, et al. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7389-93. doi: 10.1073/pnas.82.21.7389. Proc Natl Acad Sci U S A. 1985. PMID: 2932738 Free PMC article.